Kewaunee Scientific Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Thomas Hull
Chief executive officer
US$965.7k
Total compensation
CEO salary percentage | 39.8% |
CEO tenure | 5yrs |
CEO ownership | 1.2% |
Management average tenure | 5yrs |
Board average tenure | 11.8yrs |
Recent management updates
Recent updates
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely
Dec 18Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital
Jul 02Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet
Mar 10Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M
Sep 08Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M
Jun 30Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?
Apr 12Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt
Dec 28Kewaunee Scientific reports Q2 results
Dec 09CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jan 31 2024 | n/a | n/a | US$9m |
Oct 31 2023 | n/a | n/a | US$7m |
Jul 31 2023 | n/a | n/a | US$4m |
Apr 30 2023 | US$966k | US$384k | US$738k |
Jan 31 2023 | n/a | n/a | -US$629k |
Oct 31 2022 | n/a | n/a | -US$3m |
Jul 31 2022 | n/a | n/a | -US$6m |
Apr 30 2022 | US$870k | US$371k | -US$6m |
Jan 31 2022 | n/a | n/a | -US$9m |
Oct 31 2021 | n/a | n/a | -US$7m |
Jul 31 2021 | n/a | n/a | -US$4m |
Apr 30 2021 | US$707k | US$350k | -US$4m |
Jan 31 2021 | n/a | n/a | -US$2m |
Oct 31 2020 | n/a | n/a | -US$4m |
Jul 31 2020 | n/a | n/a | -US$6m |
Apr 30 2020 | US$674k | US$350k | -US$5m |
Jan 31 2020 | n/a | n/a | -US$5m |
Oct 31 2019 | n/a | n/a | -US$3m |
Jul 31 2019 | n/a | n/a | US$511k |
Apr 30 2019 | US$404k | US$280k | US$2m |
Jan 31 2019 | n/a | n/a | US$4m |
Oct 31 2018 | n/a | n/a | US$5m |
Jul 31 2018 | n/a | n/a | US$6m |
Apr 30 2018 | US$517k | US$262k | US$5m |
Jan 31 2018 | n/a | n/a | US$5m |
Oct 31 2017 | n/a | n/a | US$5m |
Jul 31 2017 | n/a | n/a | US$4m |
Apr 30 2017 | US$372k | US$256k | US$5m |
Compensation vs Market: Thomas's total compensation ($USD965.69K) is above average for companies of similar size in the US market ($USD662.11K).
Compensation vs Earnings: Thomas's compensation has been consistent with company performance over the past year.
CEO
Thomas Hull (47 yo)
5yrs
Tenure
US$965,685
Compensation
Mr. Thomas D. Hull, III, has been President and Chief Executive Officer at Kewaunee Scientific Corporation since March 11, 2019 and served as its Chief Financial Officer since November 1, 2015 until April...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 5yrs | US$965.69k | 1.19% $ 1.1m | |
VP of Finance | 4.9yrs | US$646.34k | 0.72% $ 685.6k | |
Vice President of Manufacturing Operations | 3.8yrs | US$462.58k | 0.21% $ 204.3k | |
Vice President of Sales & Marketing - Americas | 5.7yrs | US$333.87k | 0.41% $ 388.7k | |
Vice President of Human Resources | 14.8yrs | no data | 0.47% $ 448.4k | |
MD of International Operations & VP of Kewaunee Scientific Corporation Singapore Pte. Ltd. | no data | no data | no data |
5.0yrs
Average Tenure
46.5yo
Average Age
Experienced Management: KEQU's management team is seasoned and experienced (5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 5yrs | US$965.69k | 1.19% $ 1.1m | |
Independent Director | 8.9yrs | US$92.00k | 0.58% $ 549.7k | |
Independent Chairman | 15.9yrs | US$94.50k | 4.63% $ 4.4m | |
Independent Director | 29.1yrs | US$87.00k | 1.54% $ 1.5m | |
Independent Director | 10.8yrs | US$87.00k | 0.87% $ 828.0k | |
Independent Director | 12.8yrs | US$89.50k | 1.13% $ 1.1m |
11.8yrs
Average Tenure
67yo
Average Age
Experienced Board: KEQU's board of directors are seasoned and experienced ( 11.8 years average tenure).